Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyotax vs Docetaxel in Second-Line NSCLC
NCT00054184Phase 3Terminated
- Sponsor
- CTI BioPharma Corp.
- Start
- Jan 2003
- Primary completion
- Oct 2004
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel poliglumex in non-small cell lung cancer (NSCLC), sponsored by CTI BioPharma Corp.. Started Jan 2003; status: terminated.
02
Drugs
paclitaxel poliglumex
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00054184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054184.